Israel Killed 119 Palestinians in Gaza in May, the Highest Monthly Death Toll of the Year

No Accountability Submitted by QTR's Fringe Finance I honestly don’t know where Bitcoin is going from here. It could be substantially higher a year from now. It could be substantially lower. It could spend the next five years frustrating both the bulls and the bears. I’ve learned over the years that making precise price predictions about speculative assets is a fool’s errand, and I’m not interested in pretending otherwise. This article isn’t a referendum on Bitcoin, Ethereum, or digital assets generally. It’s also not an attempt to settle the endless debate between Michael...

Warsh wouldn't be offered the job if he were a departure from the usual model of Fed chairs. He'll inflate plenty, especially when recession hits.

Novo Nordisk Extends Slide After Announcing Price-Cuts For Blockbuster Obesity Drugs Novo Nordisk shares in Copenhagen can't catch a bid. The liquidation is accelerating again after a Bloomberg headline on Tuesday morning: the Danish drugmaker will slash U.S. list prices for Wegovy and Ozempic next year. The move suggests that the new CEO is pursuing market share amid intensifying competition in the GLP-1 space. Jamey Millar, Novo's head of U.S. operations, was quoted by Bloomberg as saying the company set a monthly price of $675 for its family of semaglutide drugs,...